{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:25:50Z","timestamp":1780367150905,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["P30 GM103398"],"award-info":[{"award-number":["P30 GM103398"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.toxicon.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T20:01:43Z","timestamp":1372190503000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions"],"prefix":"10.1016","volume":"72","author":[{"given":"Padmamalini","family":"Baskaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa E.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Topchiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarajan","family":"Thirunavukkarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuowei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baskaran","family":"Thyagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2013.06.014_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2012.07.015","article-title":"Reversal of BoNT\/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations","author":"Adler","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxicon.2013.06.014_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.eururo.2012.05.043","article-title":"Treatment of overactive bladder with botulinum toxin: are there more challenges to deal with?","volume":"62","author":"Apostolidis","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.toxicon.2013.06.014_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-4362.1999.00722.x","article-title":"The cosmetic uses of botulinum toxin type A","volume":"38","author":"Benedetto","year":"1999","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/toxins2040665","article-title":"Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering","volume":"2","author":"Binz","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxicon.2013.06.014_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.toxicon.2008.12.027","article-title":"Receptor and substrate interactions of clostridial neurotoxins","volume":"54","author":"Brunger","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.06.014_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10930-006-9028-1","article-title":"Botulinum neurotoxin light chain refolds at endosomal pH for its translocation","volume":"25","author":"Cai","year":"2006","journal-title":"Protein J."},{"key":"10.1016\/j.toxicon.2013.06.014_bib8","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.296.20.2476","article-title":"Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation","volume":"296","author":"Chertow","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.toxicon.2013.06.014_bib9","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1111\/j.1742-4658.2011.08205.x","article-title":"Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators","volume":"278","author":"Dolly","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.toxicon.2013.06.014_bib10","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.E08-07-0765","article-title":"Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.toxicon.2013.06.014_bib11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/092986708784221430","article-title":"Bacterial protein toxins: current and potential clinical use","volume":"15","author":"Fabbri","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.toxicon.2013.06.014_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"Foran","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2013.06.014_bib13","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1021\/bi060786z","article-title":"Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate","volume":"45","author":"Fu","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2013.06.014_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00489902","article-title":"Ultrastructural localization of acetylcholinesterase. A direct method for light and electron microscopy","volume":"76","author":"Gautron","year":"1982","journal-title":"Histochemistry"},{"key":"10.1016\/j.toxicon.2013.06.014_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1242\/jeb.19.1.14","article-title":"The rate of regeneration of nerve","volume":"19","author":"Gutmann","year":"1942","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1526-4637.2011.01245.x","article-title":"Treatment of refractory pain with botulinum toxins\u2013an evidence-based review","volume":"12","author":"Jabbari","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.toxicon.2013.06.014_bib17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/16.12.743","article-title":"Acetyl disulfide, (CH3COS)2, a major active component in the thiolacetic acid histochemical method for acetylcholinesterase","volume":"16","author":"Koelle","year":"1968","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.toxicon.2013.06.014_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbapap.2006.11.007","article-title":"Role of two active site Glu residues in the molecular action of botulinum neurotoxin endopeptidase","volume":"1774","author":"Kukreja","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.toxicon.2013.06.014_bib38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0959-440X(98)80098-5","article-title":"Unraveling the structures and modes of action of bacterial toxins","volume":"8","author":"Lacy","year":"1998","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biologicals.2012.03.004","article-title":"New equine antitoxins to botulinum neurotoxins serotypes A and B","volume":"40","author":"Li","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.toxicon.2013.06.014_bib20","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/bi992321x","article-title":"Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain","volume":"39","author":"Li","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2013.06.014_bib21","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.1021\/bi0007472","article-title":"Role of zinc binding in type A botulinum neurotoxin light chain's toxic structure","volume":"39","author":"Li","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2013.06.014_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.toxicon.2008.11.018","article-title":"Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel","volume":"54","author":"Montal","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.06.014_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.1994.tb00396.x","article-title":"Mechanism of action of tetanus and botulinum neurotoxins","volume":"13","author":"Montecucco","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib24","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1111\/j.1468-1331.2009.02583.x","article-title":"Botulinum toxin for trigeminal neuralgia","volume":"16","author":"Nurmikko","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/toxins3010063","article-title":"Towards new uses of botulinum toxin as a novel therapeutic tool","volume":"3","author":"Pickett","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2013.06.014_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.toxicon.2013.06.014_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2013.06.014_bib28","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.biochi.2010.03.005","article-title":"Clostridial neurotoxins as a drug delivery vehicle targeting nervous system","volume":"92","author":"Singh","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.toxicon.2013.06.014_bib29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3201\/eid1506.070571","article-title":"Clinical recovery and circulating botulinum toxin type F in adult patient","volume":"15","author":"Sobel","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.toxicon.2013.06.014_bib30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1212\/01.wnl.0000244417.34846.b6","article-title":"Severe botulism after focal injection of botulinum toxin","volume":"67","author":"Souayah","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2013.06.014_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1504\/TBJ.2010.039111","article-title":"Structure and trafficking potentials of botulinum neurotoxin in drug delivery","volume":"1","author":"Thirunavukkarasu","year":"2010","journal-title":"Botulinum J."},{"key":"10.1016\/j.toxicon.2013.06.014_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.109.156901","article-title":"Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a","volume":"331","author":"Thyagarajan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2013.06.014_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuropharm.2010.02.014","article-title":"Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions","volume":"58","author":"Thyagarajan","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxicon.2013.06.014_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.embor.7400796","article-title":"Entering neurons: botulinum toxins and synaptic vesicle recycling","volume":"7","author":"Verderio","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.toxicon.2013.06.014_bib35","doi-asserted-by":"crossref","DOI":"10.1096\/fj.12-210112","article-title":"Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis","author":"Wang","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.toxicon.2013.06.014_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1504\/TBJ.2008.026477","article-title":"Expression, purification and comparative characterisation of enzymatically deactivated recombinant botulinum neurotoxin type A","volume":"1","author":"Weiping Yang","year":"2008","journal-title":"Botulinum J."},{"key":"10.1016\/j.toxicon.2013.06.014_bib37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113002286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113002286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T09:50:08Z","timestamp":1645869008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010113002286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":38,"alternative-id":["S0041010113002286"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.06.014","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}